Braun Stacey Associates Inc. acquired a new position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 311,010 shares of the company’s stock, valued at approximately $28,277,000. Braun […]
First Light Asset Management LLC boosted its position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Rating) by 95.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 2,062,453 shares of the company’s stock after acquiring an additional 1,007,468 shares during the quarter. Reata Pharmaceuticals accounts for 7.3% of First Light Asset Management […]
Axa S.A. bought a new stake in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Rating) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 12,600 shares of the company’s stock, valued at approximately $317,000. Other large investors also recently added to or reduced their stakes […]